InsiderTrades

Form 4 for G Genpact LTD

Accepted 2024-11-14 00:00:00 ET · period of report 2024-11-12 · accession 0001398659-24-000107 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-11-14 2024-11-12 G Mehta Piyush SVP, CHRO S - Sale+OE $46.46 -70.0K 163.0K -30% -$3.25M
D 2024-11-14 2024-11-12 G Mehta Piyush SVP, CHRO M - OptEx $27.65 +70.0K 233.0K +43% +$1.94M
D 2024-11-14 2024-11-12 G Mehta Piyush SVP, CHRO M - OptEx $0.00 -70.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2024-11-12 S D 70,000 $46.46 163,049 D — — (F2) The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.22 to $46.72. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
2 Common Common Shares 2024-11-12 M A 70,000 $27.65 233,049 D — — (F1) Includes 347 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 15, 2024. The reporting person currently holds a total of 9,689 shares under the ESPP.
3 Derivative Employee Stock Option (Right to Buy) 2024-11-12 M D 70,000 $0.00 0 D $27.65 · — to 2026-03-31 70,000 Common Shares (F3) The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.